Tong Ren Tang Technologies Co. Ltd. (HKG:1666)

Market Cap	6.63B
Revenue (ttm)	7.73B
Net Income (ttm)	555.28M
Shares Out	1.28B
EPS (ttm)	0.43
PE Ratio	11.95
Forward PE	11.04
Dividend	0.20 (3.79%)
Ex-Dividend Date	Jun 16, 2025

Volume	1,547,000
Average Volume	1,267,969
Open	5.18
Previous Close	5.18
Day's Range	5.16 - 5.22
52-Week Range	4.40 - 6.66
Beta	1.11
RSI	62.82
Earnings Date	Aug 22, 2025

About HKG:1666

Tong Ren Tang Technologies Co. Ltd., together with its subsidiaries, produces and distributes of Chinese medicine products in Mainland China and Hong Kong. It operates through The Company and Tong Ren Tang Chinese Medicine segments. The company also offers Chinese medicinal raw materials, ointments, foot care products, healthcare products, biological products, western medicine, cosmetics, tea drinks, and food. In addition, it provides medical research and development; advertisement; Chinese medical consultation and treatment; internal and exter...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1669
• Employees: 3,991
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1666

Financial Performance

In 2024, HKG:1666's revenue was 7.26 billion, an increase of 7.18% compared to the previous year's 6.77 billion. Earnings were 521.80 million, a decrease of -11.59%.

Financial numbers in CNY